HuGE Literature Finder
Records
1
-
30
| Reevaluating the prognostic role of BRAF mutation in colorectal cancer liver metastases. American journal of surgery 2021 Sep . Pikouli Anastasia, Papaconstantinou Dimitrios, Wang Jane, Kavezou Foteini, Pararas Nikolaos, Nastos Constantinos, Pikoulis Emmanouil, Margonis Georgios Antoni |
| Cetuximab Rechallenge Plus Avelumab in Pretreated Patients With RAS Wild-type Metastatic Colorectal Cancer: The Phase 2 Single-Arm Clinical CAVE Trial. JAMA oncology 2021 Aug . Martinelli Erika, Martini Giulia, Famiglietti Vincenzo, Troiani Teresa, Napolitano Stefania, Pietrantonio Filippo, Ciardiello Davide, Terminiello Marinella, Borrelli Carola, Vitiello Pietro Paolo, De Braud Filippo, Morano Federica, Avallone Antonio, Normanno Nicola, Nappi Anna, Maiello Evaristo, Latiano Tiziana, Falcone Alfredo, Cremolini Chiara, Rossini Daniele, Santabarbara Giuseppe, Pinto Carmine, Santini Daniele, Cardone Claudia, Zanaletti Nicoletta, Di Liello Alessandra, Renato Daniela, Esposito Lucia, Marrone Francesca, Ciardiello Fortuna |
| Clinical Impact of Primary Tumor Location and Anticancer research 2021 Aug 41 (8): 3905-3915. Sato Taro, Osumi Hiroki, Shinozaki Eiji, Ooki Akira, Shimozaki Keitaro, Kamiimabeppu Daisaku, Nakayama Izuma, Wakatsuki Takeru, Ogura Mariko, Takahari Daisuke, Chin Keisho, Yamaguchi Kens |
| Cross-platform comparison of next-generation sequencing and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry for detecting KRAS/NRAS/BRAF/PIK3CA mutations in cfDNA from metastatic colorectal cancer patients. Journal of clinical laboratory analysis 2021 Aug e23818. Xu Xiaojing, Huang Fei, Cao Minlu, Chen Xinning, Wang Hao, Jiang Huiqin, Yu Yiyi, Shen Minna, Yang Yihui, Wang Beili, Liu Tianshu, Guo W |
| Tumour mutational burden, microsatellite instability, and actionable alterations in metastatic colorectal cancer: Next-generation sequencing results of TRIBE2 study. European journal of cancer (Oxford, England : 1990) 2021 Aug 155 73-84. Antoniotti Carlotta, Korn W Michael, Marmorino Federica, Rossini Daniele, Lonardi Sara, Masi Gianluca, Randon Giovanni, Conca Veronica, Boccaccino Alessandra, Tomasello Gianluca, Passardi Alessandro, Swensen Jeff, Ugolini Clara, Oberley Matthew, Tamburini Emiliano, Casagrande Mariaelena, Domenyuk Valeriy, Fontanini Gabriella, Giordano Mirella, Abraham Jim, Spetzler David, Falcone Alfredo, Lenz Heinz-Josef, Cremolini Chia |
| Phase II Trial of Trametinib and Panitumumab in RAS/RAF Wild Type Metastatic Colorectal Cancer. Clinical colorectal cancer 2021 Jul . Alshammari Kanan, Aung Kyaw L, Zhang Tong, Razak Albiruni R A, Serra Stefano, Stockley Tracy, Wang Lisa, Nguyen Jessica, Spreafico Anna, Hansen Aaron R, Zwir Dave, Siu Lillian L, Bedard Philippe |
| Association between colorectal cancer and Fusobacterium nucleatum and Bacteroides fragilis bacteria in Iranian patients: a preliminary study. Infectious agents and cancer 2021 Jun 16 (1): 41. Shariati Aref, Razavi Shabnam, Ghaznavi-Rad Ehsanollah, Jahanbin Behnaz, Akbari Abolfazl, Norzaee Samira, Darban-Sarokhalil Davo |
| Exploring clinical and gene expression markers of benefit from FOLFOXIRI/bevacizumab in patients with BRAF-mutated metastatic colorectal cancer: Subgroup analyses of the TRIBE2 study. European journal of cancer (Oxford, England : 1990) 2021 Jun 153 16-26. Moretto Roberto, Giordano Mirella, Poma Anello M, Passardi Alessandro, Boccaccino Alessandra, Tomasello Gianluca, Aprile Giuseppe, Conca Veronica, Granetto Cristina, Frassoldati Antonio, Clavarezza Matteo, Bertolini Alessandro S, Germani Marco M, Ugolini Clara, Fontanini Gabriella, Masi Gianluca, Falcone Alfredo, Cremolini Chia |
| Loss of CDX-2 expression is an independent poor prognostic biomarker in patients with early-stage deficient mismatch repair colorectal cancer. Asia-Pacific journal of clinical oncology 2021 Jun . Korphaisarn Krittiya, Sukhokanjanachusak Kanjana, Pongpaibul Ananya, Chinswangwatanakul Vitoon, Akewanlop Charuw |
| Oncological evaluation in the perioperative period using cfDNA with BRAF V600E mutation in patients with colorectal cancer. Scientific reports 2021 Jun 11 (1): 13263. Tanaka Keita, Yoshida Yoichiro, Yamada Teppei, Hayashi Takaomi, Shimaoka Hideki, Yoshimura Fumihiro, Kajitani Ryuji, Munechika Taro, Matsumoto Yoshiko, Nagano Hideki, Komono Akira, Sakamoto Ryohei, Nakashima Ryo, Aisu Naoya, Yoshimatsu Gumpei, Hasegawa Sugu |
| REMARRY and PURSUIT trials: liquid biopsy-guided rechallenge with anti-epidermal growth factor receptor (EGFR) therapy with panitumumab plus irinotecan for patients with plasma RAS wild-type metastatic colorectal cancer. BMC cancer 2021 Jun 21 (1): 674. Nakajima Hiromichi, Kotani Daisuke, Bando Hideaki, Kato Takeshi, Oki Eiji, Shinozaki Eiji, Sunakawa Yu, Yamazaki Kentaro, Yuki Satoshi, Nakamura Yoshiaki, Yamanaka Takeharu, Yoshino Takayuki, Ohta Takashi, Taniguchi Hiroya, Kagawa Yoshino |
| Clinical and epigenetic features of colorectal cancer patients with somatic POLE proofreading mutations. Clinical epigenetics 2021 May 13 (1): 117. Kawai Takashi, Nyuya Akihiro, Mori Yoshiko, Tanaka Takehiro, Tanioka Hiroaki, Yasui Kazuya, Toshima Toshiaki, Taniguchi Fumitaka, Shigeyasu Kunitoshi, Umeda Yuzo, Fujiwara Toshiyoshi, Okawaki Makoto, Yamaguchi Yoshiyuki, Goel Ajay, Nagasaka Takes |
| Clinical, Pathological and Prognostic Features of Rare BRAF Mutations in Metastatic Colorectal Cancer (mCRC): A Bi-Institutional Retrospective Analysis (REBUS Study). Cancers 2021 (9): . Calegari Maria Alessandra, Salvatore Lisa, Di Stefano Brunella, Basso Michele, Orlandi Armando, Boccaccino Alessandra, Lombardo Fiorella, Auriemma Alessandra, Zurlo Ina Valeria, Bensi Maria, Camarda Floriana, Ribelli Marta, Vivolo Raffaella, Cocomazzi Alessandra, Pozzo Carmelo, Milella Michele, Martini Maurizio, Bria Emilio, Tortora Giampao |
| CRISPR screens identify a novel combination treatment targeting BCL-X and WNT signaling for KRAS/BRAF-mutated colorectal cancers. Oncogene 2021 May 40 (18): 3287-3302. Jung Hae Rim, Oh Yumi, Na Deukchae, Min Seoyeon, Kang Jinjoo, Jang Dongjun, Shin Seungjae, Kim Jiwon, Lee Sang Eun, Jeong Eui Man, An Joon Yong, Sung Chang Ohk, Lee Won-Suk, Lee Charles, Cho Sung-Y |
| Relationships Between Köhne Category/Baseline Tumor Load and Early Tumor Shrinkage, Depth of Response, and Outcomes in Metastatic Colorectal Cancer. Clinical colorectal cancer 2021 May . Sartore-Bianchi Andrea, García-Alfonso Pilar, Geissler Michael, Köhne Claus-Henning, Peeters Marc, Price Timothy, Valladares-Ayerbes Manuel, Zhang Ying, Burdon Peter, Taieb Julien, Modest Dominik |
| BRAF V600E Mutation in First-line Metastatic Colorectal Cancer: an Analysis of Individual Patient Data from the ARCAD Database. Journal of the National Cancer Institute 2021 Mar . Cohen Romain, Liu Heshan, Fiskum Jack, Adams Richard, Chibaudel Benoist, Maughan Timothy S, Van Cutsem Eric, Venook Alan, Douillard Jean-Yves, Heinemann Volker, Punt Cornelis J A, Falcone Alfredo, Bokemeyer Carsten, Kaplan Richard, Lenz Heinz-Josef, Koopman Miriam, Yoshino Takayuki, Zalcberg John, Grothey Alex, de Gramont Aimery, Shi Qian, André Thier |
| Chemotherapy-associated clonal hematopoiesis mutations should be taken seriously in plasma cell-free DNA KRAS/NRAS/BRAF genotyping for metastatic colorectal cancer. Clinical biochemistry 2021 Mar . Huang Fei, Yang Yihui, Chen Xinning, Jiang Huiqin, Wang Hao, Shen Minna, Yu Yiyi, Liu Tianshu, Pan Baishen, Wang Beili, Guo W |
| Comprehensive analysis of mutational and clinicopathologic characteristics of poorly differentiated colorectal neuroendocrine carcinomas. Scientific reports 2021 Mar 11 (1): 6203. Lee Sun Mi, Sung Chang O |
| Histological growth patterns and molecular analysis of resected colorectal lung metastases. Pathology, research and practice 2021 Mar 222 153414. Pilozzi Emanuela, Fedele Damiano, Montori Andrea, Lorenzon Laura, Peritore Valentina, Mannocchi Giorgia, Bagheri Nikta, Leone Chiara, Palumbo Antonio, Roberto Michela, Ranazzi Giulio, Rendina Erino, Balducci Genoveffa, Ibrahim Mohs |
| Influence of BRAF and PIK3CA mutations on the efficacy of FOLFIRI plus bevacizumab or cetuximab as first-line therapy in patients with RAS wild-type metastatic colorectal carcinoma and <3 baseline circulating tumour cells: the randomised phase II VISNÚ-2 study. ESMO open 2021 Mar 6 (2): 100062. Sastre J, García-Alfonso P, Viéitez J M, Cano M T, Rivera F, Reina-Zoilo J J, Salud-Salvia A, Quintero G, Robles-Díaz L, Safont M J, La Casta A, Gil S, Polo E, Asensio-Martínez E, García-Paredes B, López R L, Guillot M, Valladares-Ayerbes M, Aranda E, Díaz-Rubio E, |
| [Analysis of influencing factors of KRAS/NRAS/BRAF/PIK3CA gene mutation consistency in patients with advanced colorectal cancer]. Zhonghua yi xue za zhi 2021 Feb 101 (6): 400-404. Jiang H Q, Wang B L, Guo |
| BRAFV600E Mutations Arising from a Left-Side Primary in Metastatic Colorectal Cancer: Are They a Distinct Subset? Targeted oncology 2021 Feb . Wong Vanessa, Lee Margaret, Wong Rachel, Tie Jeanne, Shapiro Jeremy, Desai Jayesh, Nott Louise, Steel Simone, Burge Matthew, Ma Brigette, Khattak Adnan, Hong Wei, Gibbs Pet |
| Clinicopathological Features and Prognostic Value of KRAS/NRAS/BRAF Mutations in Colorectal Cancer Patients of Central China. Current medical science 2021 Feb 41 (1): 118-126. Chang Xiao-Na, Shang Fu-Mei, Jiang Hong-Yu, Chen Chen, Zhao Zhe-Yan, Deng Sheng-He, Fan Jun, Dong Xiao-Chuan, Yang Ming, Li Yan, Cai Kai-Lin, Liu Li, Liu Hong-Li, Nie X |
| Effect of antiangiogenic-based treatment and systemic inflammatory factors on outcomes in patients with BRAF v600-mutated metastatic colorectal cancer: a real-world study in Spain. BMC cancer 2021 Jan 21 (1): 64. Martínez-Lago Nieves, Fernández-Montes Ana, Covela Marta, Brozos Elena M, De la Cámara Juan, Méndez Méndez José C, Jorge-Fernández Mónica, Cousillas Castiñeiras Antía, Reboredo Cristina, Arias Ron David, Pellón Augusto María L, González Villarroel Paula, Graña Begoña, Salgado Fernández Mercedes, Carral Maseda Alberto, Vázquez Rivera Francisca, Candamio Folgar Sonia, Reboredo López Margarita, |
| A novel xenonucleic acid-mediated molecular clamping technology for early colorectal cancer screening. PloS one 2021 16 (10): e0244332. Sun Qing, Pastor Larry, Du Jinwei, Powell Michael J, Zhang Aiguo, Bodmer Walter, Wu Jianzhong, Zheng Shu, Sha Michael |
| Fecal Multidimensional Assay for Non-Invasive Detection of Colorectal Cancer: Fecal Immunochemical Test, Stool DNA Mutation, Methylation, and Intestinal Bacteria Analysis. Frontiers in oncology 2021 11 643136. Mo Shaobo, Wang Hui, Han Lingyu, Xiang Wenqiang, Dai Weixing, Zhao Pengfei, Pei Fengchun, Su Zhixi, Ma Chengcheng, Li Qi, Wang Zhimin, Cai Sanjun, Wang Hao, Liu Rui, Cai Guoxia |
| Prevalence of colorectal cancer biomarkers and their impact on clinical outcomes in Riyadh, Saudi Arabia. PloS one 2021 16 (5): e0249590. Alharbi Amjad, Bin Dokhi Haifa, Almuhaini Ghadir, Alomran Futoon, Masuadi Emad, Alomran No |
| MAP2K1 Mutations in Advanced Colorectal Cancer Predict Poor Response to Anti-EGFR Therapy and to Vertical Targeting of MAPK Pathway. Clinical colorectal cancer 2020 Dec . Chuang Jeremy, Wang Chongkai, Guo Yuming, Valenzuela Valerie, Wu Jun, Fakih Marw |
| KRAS and BRAF mutations in Iranian colorectal cancer patients: A systematic review and meta-analysis. Caspian journal of internal medicine 2020 11 (4): 355-369. Yari Abolfazl, Afzali Asiyeh, Aalipour Mostafa, Nakheai Mehran, Zahedi Mohammad Jav |
| [Update of the recommendations for the determination of biomarkers in colorectal carcinoma. National Consensus of the Spanish Society of Medical Oncology and the Spanish Society of Pathology]. Revista espanola de patologia : publicacion oficial de la Sociedad Espanola de Anatomia Patologica y de la Sociedad Espanola de Citologia 0 54 (1): 41-54. Navarro Samuel, Cuatrecasas Miriam, Hernández-Losa Javier, Landolfi Stefania, Musulén Eva, Ramón Y Cajal Santiago, García-Carbonero Rocío, García-Foncillas Jesús, Pérez-Segura Pedro, Salazar Ramón, Vera Ruth, García-Alfonso Pil |
- Page last reviewed:Oct 1, 2021
- Page last updated:Oct 20, 2021
- Content source: